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Many patients with severe chronic obstructive pulmonary disease (COPD) report unpleasant 
respiratory sensation at rest, further amplified by adoption of supine position (orthopnoea). The 
mechanisms of this acute symptomatic deterioration are poorly understood. 
16 patients with advanced COPD and history of orthopnoea and 16 age- and sex-matched 
healthy controls (CTRL) underwent pulmonary function tests and detailed sensory-mechanical 
measurements including inspiratory neural drive (IND, diaphragm electromyography), 
oesophageal and gastric pressures in sitting and supine positions. 
Patients had severe airflow obstruction (FEV1: 40±18 %predicted) and lung 
hyperinflation. Regardless of the position, patients had lower inspiratory capacity (IC) and higher 
IND for a given tidal volume (i.e. greater neuromechanical dissociation (NMD)), higher intensity 
of breathing discomfort, minute ventilation (⩒E) and breathing frequency (Fb) compared with 
CTRL (all p<0.05). In supine position in CTRL (vs. sitting erect): IC increased (by 0.48L) with a 
small drop in ⩒E mainly due to reduced Fb (all p<0.05). By contrast, patients’ IC remained 
unaltered, but dynamic lung compliance decreased (p<0.05) in the supine position. Breathing 
discomfort, inspiratory work of breathing, inspiratory effort, IND, NMD and neuro-ventilatory 
uncoupling all increased in COPD in the supine position (p<0.05), but not in CTRL. Orthopnoea 
was associated with acute changes in IND (r=0.65, p=0.01), neuro-ventilatory uncoupling 
(r=0.76, p=0.001) and NMD (r=0.73, p=0.002).   
In COPD, onset of orthopnoea coincided with an abrupt increase in elastic loading of the 
inspiratory muscles in recumbency in association with increased IND and greater 
neuromechanical dissociation of the respiratory system.   
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Take Home Message 
Orthopnoea, a troublesome symptom in patients with severe COPD, is associated with increased 
neural drive to the diaphragm and heightened respiratory effort to compensate for abrupt 
augmentation of load-capacity imbalance of the inspiratory muscles. 
 
Plain Language Summary 
Breathing discomfort is a common symptom in patients with severe chronic obstructive 
pulmonary disease (COPD) that further worsens in the recumbent position. This study advanced 
our understanding of reasons why such patients develop sudden breathing difficulty when lying 
flat. We discovered that increased breathlessness on lying down was linked to an abrupt increase 
in the drive to breathe from “control” centers in the brain, on account of the muscles of breathing 





Dyspnoea is the most common respiratory symptom in patients with chronic obstructive 
pulmonary disease (COPD) and can be distressing even at rest, in those with severe airflow 
obstruction (1). In such patients, breathing discomfort can become further amplified on adoption 
of the supine position, i.e., orthopnoea (2-4). Indeed, in many individuals, orthopnoea may be 
problematic at night and disrupt sleep. The precise mechanisms of orthopnoea are unknown and 
their investigation presents a new opportunity to advance our understanding of the 
neurophysiology of dyspnoea.   
Proposed factors contributing to orthopnoea include impedance of diaphragmatic motion 
in the supine position which may result in further mechanical disadvantage requiring 
compensatory increases in ribcage and accessory muscle activity to maintain ventilation (2,5). 
Heijdra et al. (5) have shown lower maximal inspiratory and expiratory mouth pressures in 
supine versus sitting in patients with severe COPD reflecting increased functional weakness of 
various respiratory muscles in recumbency. Increased airway resistance in the supine position, 
due to lower end-expiratory lung volume (EELV), is potentially important, although it is unclear 
whether this is relevant in patients with severe lung hyperinflation (3,6-8). Additionally, in some 
patients, worsening pulmonary gas exchange abnormalities due to gravitational effects and 
cephaloid shift of abdominal contents, could potentially stimulate chemoreceptors to increase 
inspiratory neural drive (IND) further compounding respiratory discomfort (9,10). 
Important studies have shown that certain positions adopted by individual patients to 
relieve dyspnoea (e.g., “forward-leaning”) are associated with improved ability to generate 
maximal inspiratory pressures and improved length-tension relationships, neuromechanical 
efficiency of the diaphragm and reduced neuromechanical dissociation (NMD) of the respiratory 
system (2,4,11). This raises the question whether the opposite is true, i.e., that orthopnoea 
 
 
reflects acute increases in inspiratory muscle dysfunction and reduced diaphragmatic efficiency. 
Collectively, most studies undertaken to-date lack validated measurements of dyspnoea intensity 
and included participants with heterogeneous physiological abnormalities and have not, 
therefore, permitted any definitive or unitary conclusions about the origins of orthopnoea in 
COPD.  
Current constructs of the origins of dyspnoea in chronic lung diseases emphasize the 
importance of increased IND from cortical motor centres in the brain, secondary to load-capacity 
imbalance of the respiratory muscles (12,13). Advanced COPD showed higher IND (estimated 
by diaphragm electromyography (EMGdi)) at rest compared to healthy controls (14). Recent 
studies in which exercise was used as the provocative stimulus for dyspnoea, have shown that 
increased exertional dyspnoea intensity ratings are strongly associated with increased IND and 
increased disparity between IND and the mechanical response of the respiratory system (i.e. 
NMD) (15-19). Moreover, interventions that reduced mechanical loading of the inspiratory 
muscles (e.g. bronchodilators) or that improved their strength (e.g. inspiratory muscle training) 
are associated with reduced IND, and dyspnoea intensity in COPD (20,21). Accordingly, we 
postulated that orthopnoea is related to acute amplification of IND and NMD due to sudden 
deterioration in load-capacity ratio of already compromised inspiratory muscles in supine 
position. To test this hypothesis, we measured changes in dyspnoea intensity, IND, NMD, 
dynamic lung mechanics and pulmonary gas exchange during the transition from seated to 




We included sixteen patients with COPD: age≥45 years; post-bronchodilator forced expiratory 
 
 
volume in one-second <80 %predicted; a cigarette smoking history ≥20 pack-years; clinically 
stable but with long-standing orthopnoea. Exclusion criteria: body mass index (BMI) >35 kg/m
2
; 
use of oxygen; history of asthma or other respiratory/cardiovascular disease that could contribute 
to dyspnoea or orthopnoea (e.g. heart failure). Sixteen non-smoking age-matched CTRL were 
also included. Participants were recruited from a database of volunteers at the Respiratory 
Investigation Unit and respiratory outpatient clinics at Kingston Health Sciences Centre 
(Kingston, ON, Canada). 
Study design 
This cross-sectional prospective study received ethical approval from the Queen’s University and 
Affiliated Teaching Hospitals Research Ethics Board (DMED-1989-16). After providing 
informed consent, participants completed one visit, which included eligibility screening, 
symptom and quality of life (QoL) questionnaires (22-25), and pulmonary function tests (PFTs). 
We continuously measured EMGdi and respiratory pressures at rest while sitting erect then, after 
10 minutes, in supine position using a double-ballooned multi-electrode oesophageal catheter. In 
each position, participants performed a series of cough, sniff and inspiratory capacity (IC) 
manoeuvres. Participants spent at least 5-minutes of quiet breathing while on a mouth piece to 
collect breath-by-breath breathing pattern and metabolic parameters.  
Procedures 
Spirometry, plethysmography, lung diffusing capacity for carbon monoxide (DLCO), maximal 
inspiratory (MIP) and expiratory (MEP) mouth pressures were performed (Vmax229d, 
AutoboxV62J; SensorMedics, Yorba Linda, CA). Questionnaires included: modified Medical 
Research Council (MRC) dyspnoea scale (23), baseline dyspnoea index (BDI) (22), COPD 
assessment test (CAT) (25), and St. George Respiratory Questionnaire (24). Breath-by-breath 
breathing pattern and metabolic parameters (SensorMedics-Vmax229d), oxygen saturation by 
 
 
pulse oximetry (SpO2) and heart rate (12-leads electrocardiogram) were collected.  
At the end of quiet breathing period, participants were asked, using the modified 10-point 
Borg scale (26) to rate their intensity of breathing discomfort (how strong?): [0 indicating no 
discomfort, 10 maximal discomfort they ever experienced or could imagine experiencing] and 
quality of breathing discomfort (what breathing feels like?) in 5 domains: overall intensity, 
difficulty breathing in, difficulty breathing out, increased work/effort and unpleasantness (27).  
EMGdi and respiratory pressures: data represent 30 participants as one in each group 
declined catheter insertion after initial agreement. A multi-electrode EMGdi catheter with 
oesophageal and gastric balloons was inserted nasally (16). EMGdi and respiratory pressures 
were continuously recorded and analysed (14,16,28). Raw EMGdi signal was sampled at 2,000 
Hz (PowerLab-model-ML880; ADInstruments, Bella Vista, Australia), band-pass filtered 
between 20 and 1,000 Hz (Bioamplifier model-RA-8; Guanzhou Yinghui Medical Equipment 
Co., Guangzhou, China), and converted to a root mean square (RMS). For each breath, data from 
the electrode pair (from the five pairs) with the largest inspiratory RMS value were used for 
analysis. EMGdi,max was determined during maximal sniff or IC manoeuvres The oesophageal 
and gastric balloons were connected to differential pressure transducers to obtain oesophageal 
(Pes) and gastric pressures (Pga). Trans-diaphragmatic pressure (Pdi) was calculated as the 
difference between Pes and Pga. Pdi,max and Pes,max were determined during maximal sniff 
manoeuvres (29). Tidal EMGdi as a percentage of EMGdi,max (EMGdi%max) and tidal Pdi as a 
percentage of Pdi,max (Pdi%max) were used as indices of the IND to the crural diaphragm and 
inspiratory effort, respectively (14,16,28). Ratios of EMGdi%max to tidal volume (VT)/predicted 
vital capacity (VC), EMGdi%max:tidal Pdi%max and EMGdi%max:minute ventilation (⩒E) were 
used as indices of NMD, neuromuscular efficiency of the diaphragm, and neuro-ventilatory 
coupling, respectively. Expiratory flow limitation (EFL) was assessed as the % of VT that 
 
 
overlapped the maximal flow volume loop of each position (VFL) (30). The PowerLab system 
received continuous flow signal input from the Vmax229d system for analysis. Airway 
resistance, dynamic lung compliance (CL,dyn) and work of breathing (WOB) were calculated as 
previously described (16). More details are provided in the online-supplement.  
Statistics: 
A sample size of 16 was estimated to provide 80% power to detect a 1 Borg-unit difference in 
dyspnoea intensity between-groups, based on a SD of one unit, α of 0.05, and a two-tailed test of 
significance. Unpaired t-test was used for between-group comparisons and paired t-test to 
compare responses in sitting versus supine positions within groups. Linear regression was used 
to test the relationship between supine-sitting change in dyspnoea intensity and relevant 
independent variables in patients. Statistical significance was set at p<0.05.  
Results 
Subjects characteristics and PFTs 
Thirty COPD patients were screened: 14 were excluded (either because they didn’t report long-
standing orthopnoea and/or declined catheter insertion). Subjects’ characteristics (Table 1, 
online-supplement): groups were matched for age, sex, height, and BMI. Three CTRL (with 
normal PFTs) had an insignificant smoking history and had stopped smoking for >30 years at the 
time of the study. Patients had greater activity-related dyspnoea (MRC dyspnoea scale and BDI), 
higher CAT scores, and poorer QoL compared with CTRL (all p<0.001). None of the 
participants had any clinical evidence of significant cardiac or pulmonary vascular disease that 
could contribute to orthopnoea. Other comorbidities and medications are shown in the online-
supplement.  
Compared to CTRL, patients had higher residual volume/total lung capacity (TLC) and 
 
 
lower DLCO, resting sitting IC, maximal voluntary ventilation, MIP and MEP (all p<0.01), table 
1. The ratio of alveolar volume measured by single-breath gas dilution to plethysmographic-TLC 
was lower in patients compared with CTRL (p<0.0001) while TLC was not different between 
groups.  
Impact of COPD on dyspnoea, IND and ventilatory mechanics  
Tables 2 and 3 summarize measurements in the supine and sitting positions. Patients had greater 
dyspnoea in all 5 domains in both positions compared with CTRL (all p<0.05), table 2. In COPD 
patients, compared with CTRL, and regardless of body position, ⩒E and ventilatory inefficiency 
(ventilatory equivalent for carbon dioxide (⩒E/⩒CO2)) were consistently higher; in the presence 
of lung hyperinflation (higher EELV, lower IC and inspiratory reserve volume (IRV)) and 
greater EFL (VFL) (all p<0.01). VT and PetCO2 were not different from CTRL in both positions 
(figure 1, table 2). Pdi,max and Pes,max were lower (more negative) and airway resistance, total 
WOB, tidal EMGdi, IND, inspiratory effort and neuro-ventilatory uncoupling, were all greater in 
COPD vs. CTRL in both positions, all p<0.05 (table 3).  
Impact of supine posture on dyspnoea, IND and ventilatory mechanics 
Dyspnoea ratings increased significantly in the transition from seated to supine position in 
COPD patients (p<0.05), while CTRL reported no breathlessness (table 2, online-supplement). 
In supine (vs. sitting), CTRL’s IC increased by 0.48L (p<0.001) (figure 1, online-supplement) 
likely reflecting lower EELV; this was associated with lower ⩒E, ⩒E/⩒CO2, ⩒E/⩒O2, and 
breathing frequency (Fb) (all p<0.05) with no change in VT (figure 1, table 2). In contrast to 
CTRL, patients’ IC, EELV, ⩒E, and Fb did not change in the supine position (table 2, figure 1). 
VT also remained unchanged. In supine vs. sitting, patients had lower ⩒E/⩒O2 and ⩒E/⩒CO2 
 
 
(p=0.001) reflecting a slightly lower ⩒E (p=0.07) while ⩒O2 and ⩒CO2 remained unchanged. 
End-tidal CO2 (PetCO2) did not change with position in CTRL, but slightly increased by 1.2 
mmHg in supine vs. sitting position in COPD patients (p=0.003). There was a minor drop in 
SpO2 in supine vs. sitting by 1% in CTRL (p=0.003) and by 0.7% in patients (p=0.02) (table 2).  
In CTRL, supine positioning was associated with a small reduction in Pes,max (p=0.01), 
Pdi,max (p<0.01) and EMGdi,max (p=0.004), table 3, online-supplement. There were no 
differences in tidal EMGdi, IND, airway resistance, WOB, inspiratory effort, NMD, 
neuromuscular efficiency of the diaphragm or neuro-ventilatory coupling, but CL,dyn was lower 
(p=0.04) and VFL was higher (p=0.001) in supine vs. sitting (table 3, figure 2). Expiratory 
muscle activity was reduced while supine [lower tidal expiratory Pga,max (p==0.004) and end-
expiratory Pga (p=0.047) in supine vs. sitting], table 3.   
Similar to CTRL, supine posture in COPD patients was associated with reductions in 
EMGdi,max, Pdi,max, CL,dyn and expiratory muscle activity (all p<0.05) with no change in 
airway resistance, table 3, online-supplement. Absolute tidal EMGdi was not different on 
average but has risen in 53% of patients while supine, table 3, online-supplement. Moreover, in 
patients with COPD, supine posture was associated with greater IND, NMD, neuro-ventilatory 
uncoupling and total inspiratory WOB (all p<0.05), but neuromuscular efficiency of the 
diaphragm was unaltered, table 3, figure 2. Elastic WOB was also greater in supine vs. sitting 
(p=0.06), table 3. Unlike CTRL, patients had greater inspiratory effort and ratio of 
Pdi%max:VT%VC in supine vs. sitting position (table 3, figure 2). A descriptive summary of the 
physiological changes associated with supine compared with sitting posture in CTRL and 
patients with COPD is shown in table 4.  
In COPD patients, sitting-to-supine change in CL,dyn correlated with corresponding 
changes in elastic WOB (r=0.74, p=0.003). In addition, sitting-to-supine change in dyspnoea 
 
 
intensity correlated with corresponding changes in IND (r=0.65, p=0.01), NMD (r=0.73, 
p=0.002) and neuro-ventilatory uncoupling (r=0.76, p=0.001), figure 3.  
 
DISCUSSION 
The results support the hypothesis that, compared with healthy controls, transition from sitting to 
supine position in mechanically compromised patients with COPD was associated with acutely 
increased dyspnoea intensity that was linked to corresponding increases in neuromechanical 
dissociation of the respiratory system due to sudden decreases in dynamic lung compliance.  
This study included a well-characterized group of patients with severe airway 
obstruction, lung hyperinflation, persistent chronic dyspnoea and orthopnoea. Compared with 
healthy controls, patients had higher ventilatory requirements, IND (~2-fold), inspiratory effort 
and WOB together with lower IC and IRV, regardless of the position. Additionally, patients had 
higher resistive and elastic loading of functionally weaker inspiratory muscles compared with 
controls.     
In healthy individuals, supine positioning was associated with a small (albeit significant) 
drop in ⩒E at a given ⩒CO2 primarily due to reduced Fb (figure 1), without any change in 
respiratory sensation (31,32). Interestingly, IC increased in recumbency (by 0.48 L) in the 
current study (figure 1), consistent with an earlier report by Brody et al. (33). This increase in IC 
suggests a relatively large decrease in supine EELV, assuming TLC remained unchanged as 
previously reported  (34,35). It is noteworthy that maximal inspiratory oesophageal and trans-
diaphragmatic pressures slightly decreased in recumbency suggesting reduced functional static 
inspiratory muscle strength. Based on previous studies, reduction in supine EELV was likely due 
to a combination of decreased chest wall compliance, increased thoracic blood volume, 
gravitational re-distribution of visceral weight and cephaloid shift of the diaphragm (33,36-38). 
 
 
Recumbency in the healthy elderly is associated with increased small airway closure, more 
uneven distribution of inspired gas and ultimately greater heterogeneity in mechanical time 
constants (i.e. product of compliance and resistance) with preferential ventilation of alveolar 
units with fast time constants for emptying (7,8). Indeed, in our CTRL group (average age 69 
years), EFL (as crudely assessed by the VT tidal vs. maximal flow-volume loop method (30)) 
was increased and dynamic lung compliance was decreased in the supine position with little 
change in total airway resistance (6). The decrease in dynamic lung compliance in the supine 
position did not have a deleterious effect on respiratory symptoms in healthy controls: it led to a 
slight, albeit insignificant, increase in the elastic WOB which was accommodated by normally-
functioning inspiratory muscles in the setting of normal respiratory mechanics. 
As such, despite these acute dynamic mechanical changes and small decreases in 
maximal inspiratory pressures, IND for a given VT or ⩒E, WOB and neuromuscular efficiency of 
the diaphragm were not different in supine versus seated positions in CTRL (table 3, figure 2). 
This latter finding is in keeping with previous observations that effective compensatory 
mechanisms are at play in health (39,40). One such adaptation is that cephaloid shift of the 
diaphragm is associated with improvement in length-tension relationship and increased zone of 
apposition which helps to preserve its ventilatory function and mitigate a fall in alveolar 
ventilation in the supine position (39,40).  
COPD patients transitioning to the supine position reported abrupt onset of unpleasant 
respiratory sensations (table 2). In contrast to CTRL, the relatively diminished seated IC 
remained unchanged on recumbency suggesting an unaltered EELV (figure 1, online-
supplement), which is not surprising in the setting of severe resting lung hyperinflation 
(10,33,35,41). VT was well preserved and there was no supine decrease in Fb as seen in CTRL.  
 
 
Maximal inspiratory Pes was similar in both positions, but Pdi,max and expiratory 
Pga,max decreased on recumbency, suggesting reduced contribution of the diaphragm to overall 
pressure generation of the respiratory pump. In other words, additional inspiratory and accessory 
muscles were likely recruited during the maximal inspiratory manoeuvre to TLC while supine.  
Expiratory muscle activity (tidal expiratory Pga,max and end-expiratory Pga) was lower 
in supine versus sitting positions, suggesting reduced abdominal muscle contribution to 
ventilation (42-44), as previously shown by Druz and Sharp (42).  
The reduced fixed IC means that VT continues to be positioned close to TLC and the 
upper poorly-compliant portion of the relaxed respiratory system pressure-volume relation in 
COPD, where there is increased elastic/threshold loading of functionally weakened inspiratory 
muscles. This is further compounded in recumbency by acutlely decreased dynamic lung 
compliance by 48 ml/cmH2O in the setting of a stable breathing pattern and lack of a significant 
increase in airway resistance. The cause of reduced dynamic lung compliance is multifactorial 
and potentially include those factors mentioned above: increaed small airway closure with 
variable atelectasis and regional lung hyperinflation, increased EFL as suggested by VT/maximal 
flow-volume loop overlap calculations; maldistribution of inspired gas and greater mechanical 
time constant inhomogeneity (45). Other possible contributors established from previous studies 
include gravitational effects such as increased pulmonary blood volume and increased thoraco-
abdominal asynchrony and chest wall distortion leading to reduced lung distensibility (7,45).  
Unlike the situation in CTRL, acute elastic loading of this nature had immediate 
deleterious consequences in these individuals who were already mechanically compromised (by 
resting hyperinflation and impaired inspiratory muscle function). Effort and WOB of the 
inspiratory muscles increased in association with an augmented IND. While neuromucular 
efficiency of the diaphragm was largely unaltered, overall compensatory strategies were less 
 
 
effective than in CTRL. Thus, the wide disparities between increased IND and the mechanical 
and ventilatory responses of the respiratory system evident while sitting were acutely amplified 
by adopting the supine posture.  
On recumbency and despite the compensatory increase in IND in patients with COPD, 
there was a modest reduction in ⩒E but the ventilatory equivalent for ⩒CO2, which would be 
expected to rise due to decreased ventilatory efficiency, actually fell significantly by 5 L/min in 
keeping with acute mechanical deterioration and associated ventilatory constraints. This was 
associated with a small rise in PetCO2 and reduction in SpO2 of uncertain clinical significance.  
Mechanisms of orthopnoea in patients with COPD  
Dyspnoea intensity (severity) was increased in the supine versus sitting posture by an average of 
1.2 Borg units in our patients (table 2). In qualitative terms, patients described greater difficulty 
in breathing in and out, and reported “my breathing requires more work or effort” and “my 
breathing feels unpleasant”. In general, greater dyspnoea is associated with greater IND and 
inspiratory effort as a result of greater mechanical loading of the inspiratory muscles, increased 
chemical drive or both in combination (16). The sudden increase in acute elastic mechanical 
loading worsened load/capacity imbalance of the insiratory muscles, such that compensatory 
increases in IND were required. Accordingly, the data support the postulation that increased 
central command output from cortical motor centers to the inspiratory muscles and the attendent 
increased central corrolary discharge from these centers to the somato-sensory cortex are key 
mechanisms of orthopnoea (46). However, altered afferent inputs from abundant sensory 
receptors throughout the respiratory system (which cannot be easily measured), in response to 
sudden increases in elastic loading, also likely influenced perception of the intensity and quality 
of dyspnoea. Certainly, it is reasonable to implicate short term alterations in afferent feedback 
from mechanoreceptors in the inspiratory muscles and the chest wall (muscle spindles and Golgi 
 
 
tendon organs) in the genesis of such unpleasant respiratory sensations (47). In the current study, 
the consistent association between increases in respiratory discomfort in the sitting-supine 
transition and parallel increases in measures of IND, NMD and neuro-ventilatory mismatching 
(explaining 40-50% of the variance in orthopnoea) further support this contention (figure 3).  
Limitations 
The sample size is small, but was sufficient to uncover significant differences in the parameters 
of interest between patients and CTRL and within patients (15,16). We obtained EMG 
measurements of the crural diaphragm only and cannot comment on concomitant electrical 
activity of the ribcage and accessory muscles. We must acknowledge, when considering 
positional differences in the mechanical properties of the lungs, that intra-oesophageal pressure 
can deviate from intra-pleural pressure in the supine position due to a direct pressure of the heart 
or other mediastinal structures on the oesophagus (6). Our study did not permit us to assess 
potential “peripheral” influences on the intensity/quality of perceived orthopnoea, that may arise 
directly from alterted afferent feedback from various sensory receptors in the respiratory 
muscles, chest wall, lungs  and cardio-vascular system.  Lastly, we acknowledge that our results 
cannot be generalized to all COPD patients; those without orthopnoea or those with significant  
comorbidities. 
Conclusion 
In patients with severe COPD, onset of orthopnoea coincided with an abrupt increase in 
amplitude of IND from an already elevated sitting value. This increased IND occurred in 
response to acute elastic loading of the functionally weakened inspiratory muscles and further 
amplified the pre-existing disparity between increased IND and the mechanical and ventilatory 
responses of the respiratory system.  
 
 
Our study is the first to demonstrate that the presence of persistent orthopnoea in patients 
with advanced COPD points to the existance of severe mechanical compromise and very high 
resting IND and NMD, even in the absence of significant pulmonary gas exchange 
abnormalities. The corollary is that a central goal of management in such patients must be to 
improve respiratory mechanics so as to effectively reduce IND and NMD, as recently 
demonstrated (48). To the extent that orthopnoea can seriously disrupt sleep in patients with 
advanced COPD, every effort should be made to individualize bronchodilator treatment to 
achieve sustained “24-hour” bronchodilatation and lung deflation.  
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Table 1: Subjects Characteristics and Pulmonary Function Test 
Variable COPD (n=16, M:F= 9:7) CTRL (n=16, M:F= 8:8) 
Age, years 66±7 69±7 
Height, cm 168±10 167±7 
Body mass, Kg 71±17 76±11 
BMI, Kg/m
2
 25±6 27±3 
Smoking history, pack-years 52.2±24.9* 1.8±3.5 
Smoking status, % current smokers 25 0 
Modified MRC dyspnoea scale (0-4) 2.7±0.9* 0.2±0.4 
BDI focal score (0-12) 5.0±1.8* 11.6±0.7 
Pulmonary Function Test 
FEV1, L 0.96±0.39* (40±18*) 2.70±0.63 (115±28) 
FVC, L 2.67±0.86* (73±15*) 3.74±0.66 (110±15) 
FEV1/FVC, % 37±14* (53±20*) 70±7 (101±11) 
PEF, L/s 3.54±1.28* (53±22*) 7.40±1.32 (113±15) 
FEF25-75%, L/s 0.35±0.18* (14±8*) 1.82±0.96 (75±38) 
IC, L 1.89±0.55* (69±16*) 2.99±0.74 (114±20) 
FRC, L 4.92±1.77* (151±42*) 3.15±0.63 (100±16) 
TLC, L 6.81±1.91 (113±18) 6.05±0.93 (105±10) 
RV, L 3.80±1.43* (172±60*) 2.11±0.54 (94±18) 
RV/TLC, % 55±11* 35±7 
DLCO, ml/min/mmHg 7.67±2.85* (40±18*) 17.72±3.61 (89±17) 
DL/VA, ml/min/mmHg/L 2.06±0.69* (52±24*) 3.38±0.53 (92±13) 
VA, L 3.85±0.87* 5.25±0.80 
VA/TLC 0.53±0.19* 0.87±0.06 
sRaw, cmH2O•s 28.9±16.4* (686±385*) 7.7±4.6 (184±104) 
MVV, L/min 35.8±11.0* (32±13*) 109.6±27.3 (107±20) 
MIP, cmH2O 66±21* (80±39*) 100±32 (134±39) 
MEP, cmH2O 114±40 (57±30*) 133±61 (79±27) 
Values are means±SD. Percentage of predicted normal values for pulmonary function test are 
shown in parentheses. * p<0.05 COPD vs. CTRL group. 
Abbreviations: BDI= Baseline Dyspnoea Index; BMI= body mass index; COPD= chronic obstructive 
pulmonary disease; CTRL= healthy controls; DLCO = diffusing capacity of the lung for carbon 
monoxide; DL/VA = DLCO corrected for alveolar volume; F= female; FEF25-75%= forced expiratory flow 
between 25 and 75% of forced vital capacity; FEV1/FVC= ratio between FEV1 and forced vital capacity; 
FEV1= forced expired volume in 1 s; FRC= functional residual capacity; FVC= forced vital capacity; IC= 
inspiratory capacity; M=male; MEP= maximum expiratory mouth pressure; MIP= maximum inspiratory 
mouth pressure; MRC= Medical Research Council; MVV= maximal voluntary ventilation; PEF= peak 




Table 2: Cardio-respiratory and metabolic measurements in sitting and supine positions 
Variable 
COPD (n=16) CTRL (n=16) 
Sitting Supine Sitting Supine 
⩒O2, L/min 0.26±.0.05 0.26±0.06 0.28±0.06 0.29±0.05 
⩒CO2, L/min 0.21±0.05 0.21±0.05 0.23±0.05 0.21±0.04 
⩒E, L/min 12.11±1.7† 11.20±1.76† 9.75±1.97* 8.46±1.87 
IC, L 2.05±0.73† 2.13±0.78† 3.02±0.79* 3.49±0.77 
VT, L 0.65±0.16 0.62±0.19 0.68±0.14 0.67±0.12 
Fb, breaths/min 19.9±4.4† 19.7±6.1† 15.3±3.0* 13.4±3.3 
TI/TTOT 35.3±5.8† 37.1±7.2† 44.8±5.3* 
 
55.1±9.5 
TI, sec 1.19±0.26† 1.58±1.17† 2.03±0.70* 3.06±1.22 
IRV, L 1.35±0.57*† 1.46±0.61† 2.33±0.72 2.70±1.13 
⩒E/⩒O2 47.7±6.1*† 42.5±5.8† 35.9±6.0* 29.3±3.5 
⩒E/⩒CO2 59.1±9.6*† 54.3±8.1† 44.6±6.2* 40.1±4.5 
PetCO2, mmHg 31.8±4.7* 33.0±4.2 34.2±3.2 34.6±1.9 
Heart rate, beats/min 72±8 70±9 70±10* 65±7 
SpO2, % 94.5±2.4* 93.8±2.6 95.4±1.4* 94.2±1.1 
VFL, % 83.7±12.0*† 95.6±5.9† 25.5±29.6* 67.0±27.0 
Dyspnoea (Borg scale 0-10) 
 Overall intensity  
 Difficulty breathing in 
 Difficulty breathing out 


























Values are means±SD.  
*p<0.05 sitting vs. supine within COPD or CTRL. †p<0.05 COPD vs. CTRL. 
Abbreviations: ⩒CO2= carbon dioxide production; ⩒E/⩒CO2= ventilatory equivalent for carbon 
dioxide; ⩒E/⩒O2= ventilatory equivalent for oxygen; ⩒E= minute ventilation; ⩒O2= oxygen 
consumption; COPD= chronic obstructive pulmonary disease; CTRL= healthy controls; Fb= 
breathing frequency; IC= inspiratory capacity; IRV= inspiratory reserve volume; PetCO2= partial 
pressure of end-tidal carbon dioxide; SpO2= oxygen saturation measured by pulse oximetry; 
TI/TTOT= inspiratory duty cycle; TI= inspiratory time; VFL= % of tidal volume that overlapped 
maximal flow volume loop; VT= tidal volume. 
 
 
Table 3: Respiratory pressures and EMGdi measurements in sitting and supine positions  
Variable 
COPD (n=15) CTRL (n=15) 
Sitting Supine Sitting Supine 
Inspiratory muscle activity  
Inspiratory Pes, max, cmH2O 44.9±11.0† 43.0±13.6† 67.4±17.0* 61.2±17.6 
Tidal inspiratory Pes, cmH2O 9.9±2.8† 10.5±3.8† 3.2±1.7 4.2±2.4 
Tidal Pes%max, % 24±11*† 29±17† 5±3* 7±5 
Pdi, max, cmH2O 79±23*† 69±20† 96±18* 80±21 
Tidal Pdi, cmH2O 10.4±2.6† 11.6±3.2† 5.4±2.6 5.8±3.8 
Tidal Pdi%max, % 14±5*† 19±10† 6±3 8±6 
Tidal Pdi%max:VT%predVC 0.75±0.31*† 1.10±0.65† 0.30±0.17 0.40±0.29 
Expiratory muscle activity  
Tidal expiratory Pga, max, 
cmH2O 
24.6±13.4* 18.1±12.9 17.7±9.7* 12.6±7.3 
Pga, end expiratory, cmH2O 22.3±14.2* 17.0±13.5 15.0±10.8* 11.2±7.9 
EMGdi measurements 
Tidal EMGdi, µV 46.9±17.4† 50.4±19.6† 20.1±8.0 17.4±6.8 
EMGdi,max, µV 185±42* 160±58 164±33* 139±26 
EMGdi%max:⩒E 2.10±0.69*† 2.93±1.17† 1.37±0.64 1.57±0.74 
EMGdi%max, % 25±7*† 33±13† 13±6 13±5 
EMGdi%max:VT%predVC 1.35±0.49*† 1.92±1.10† 0.66±0.37 0.65±0.28 
EMGdi%max:tidal Pdi%max 2.06±1.08 2.21±1.29 2.74±1.41 3.05±2.87 
Extra measurements of respiratory mechanics  
CL,dyn, ml/cmH2O 168±96*† 120±77† 281±83* 232±106 
Airway resistance, cmH2O/L/sec 7.40±3.09† 7.74±3.45† 1.80±1.14 2.42±1.60 
Total inspiratory WOB (J) 7.17±2.37*† 10.16±4.14† 1.87±1.28 2.46±1.86 
Total expiratory WOB (J) 1.76±0.81† 1.36±1.20† 0.16±0.21 0.17±0.24 
Elastic WOB (J) 3.10±0.98† 4.21±2.39† 1.16±0.75 1.64±1.20 
Resistive WOB (J) 4.07±1.60† 4.95±2.35† 0.71±0.66 0.82±0.71 
Values are means±SD. *p<0.05 sitting vs. supine within COPD or CTRL. †p<0.05 COPD vs. 
CTRL. 
Abbreviations: CL,dyn =dynamic lung compliance; COPD= chronic obstructive pulmonary disease; 
CTRL= healthy controls; EMGdi%max:⩒E=neuro-ventilatory coupling; EMGdi%max:tidal Pdi%max=   
neuromuscular efficiency of the diaphragm; EMGdi%max:VT%predVC= measure of neuromechanical 
dissociation of the respiratory system; EMGdi%max= measure of inspiratory neural drive to the diaphragm; 
EMGdi= diaphragm electromyography; Pdi= trans-diaphragmatic pressure; Pes= oesophageal pressure; 
Pga= gastric pressure; tidal expiratory Pga,max = the maximum expiratory gastric pressure during tidal 
breathing; VC= vital capacity; VT= tidal volume; ⩒E= minute ventilation; WOB= work of breathing. 
 
 
Table 4: Summary of physiological changes associated with supine posture compared with 
sitting posture  
Variable 
Patients with advanced 
COPD and orthopnoea 
Healthy controls 
Inspiratory capacity, L  -   
EELV, L -  
Minute ventilation, L/min -  
⩒E/⩒CO2   
Tidal volume, L - - 
Dynamic compliance, ml/cmH2O   
Inspiratory effort (Tidal Pdi%max)  - 
Expiratory muscle activity   
Total inspiratory WOB, J  - 




Neuromechanical dissociation  - 
Neuroventilatory uncoupling  - 
Dyspnoea Borg ratings  - 
Abbreviations: ⩒E/⩒CO2= ventilatory equivalent for carbon dioxide; COPD= chronic obstructive 
pulmonary disease; EELV= end-expiratory lung volume; EMGdi= diaphragm electromyography; 




Figure 1. Breathing pattern parameters in sitting and supine positions in patients with advanced 
COPD and age-matched healthy controls (CTRL). Boxes depict the first to third quartiles; central 
lines denote the median. Whiskers range from the 10th to the 90th percentile. Abbreviations: 
COPD= chronic obstructive pulmonary disease; Fb= breathing frequency.  
 
Figure 2. Inspiratory neural drive by diaphragm electromyography (EMGdi) and respiratory 
pressure measurements in sitting and supine positions in patients with advanced COPD and age-
matched healthy controls (CTRL). Boxes depict the first to third quartiles; central lines denote 
the median. Whiskers range from the 10th to the 90th percentile. Abbreviations: COPD= chronic 
obstructive pulmonary disease; CL,dyn= dynamic lung compliance; Pdi= trans-diaphragmatic 
pressure; WOB= work of breathing; ⩒E=minute ventilation; VT= tidal volume.  
 
Figure 3. There was a significant correlation between supine-sitting change in dyspnoea 
intensity (Borg scale) and corresponding changes in: (a) inspiratory neural drive (IND) (r-
square=0.42, p=0.01); and (b) neuro-ventilatory coupling (r-square=0.57, p=0.001) and (c) 
neuromechanical dissociation (NMD) (r-square=0.53, p=0.002). Dashed lines represent the 95% 
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Methods 
Pulmonary function test 
Spirometry, body plethysmography, single-breath lung diffusing capacity for carbon monoxide 
(DLCO) and maximal inspiratory (MIP) and expiratory (MEP) mouth pressures were performed 
using automated equipment (Vmax229d, AutoboxV62J; SensorMedics, Yorba Linda, CA). 
Measurements were expressed relative to predicted normal values (1,2). 
Diaphragm electromyography and respiratory pressure measurements 
Diaphragm electromyography (EMGdi), oesophageal pressure (Pes) and gastric pressure (Pga) 
were measured continuously using a combined electrode-balloon catheter system (3-7). The 
EMGdi signal was sampled at 2000 Hz (PowerLab, model ML880; ADInstruments, CastleHill, 
NSW, Australia), band-pass filtered between 20-1000 Hz (Bioamplifier model RA-8; Guanzhou 
Yinghui Medical Equipment Co. Ltd, Guangzhou, China) and converted to a root mean square  
(RMS) to assess respiratory neural activity. The data from the electrode pair showing the highest 
RMS value from the five electrode pairs in each inspiration was used for analysis. The 
oesophageal and gastric balloons were inflated with 1.0 mL and 1.2 mL of air, respectively. Pes 
and Pga were measured using differential pressure transducers (model DP15-34; Validyne 
Engineering, Northridge, CA, USA) and sampled at a rate of 100 Hz (PowerLab); trans-
diaphragmatic pressure (Pdi) was calculated by subtraction of Pes from Pga. The continuous flow 
signal from the Vmax229d system (SensorMedics, Yorba Linda, CA) was simultaneously input 
into the data-acquisition system for analysis. 
Maximal EMGdi (EMGdi,max) was determined as the highest inspiratory RMS from any 
sniff/inspiratory capacity manoeuvre performed during the test (8). Inspiratory sniffs were used to 
obtain maximum Pes (Pes,max) and maximum Pdi (Pdi,max) (6,9). Tidal Pes swings (Pes,tidal) 
were defined as the amplitude between the maximum expiratory value and minimum inspiratory 
value for each respiratory cycle. The tidal Pdi swing was defined as the amplitude of the Pdi 
waveform during tidal breathing.  
End-inspiratory (EI) and end-expiratory (EE) data points of zero flow for Pes and Pga were 
collected. Dynamic compliance (CL,dyn) was calculated as the change in lung volume divided by 
change in Pes between EE and EI (10). Lung elastic work was calculated from the dynamic 
relation between Pes and lung volume in Campbell diagrams (11,12). Airway resistance was 
calculated as the difference in Pes divided by the difference in flow at inspiratory mid-volume and 
expiratory iso-volume (ΔPes/Δflow) (10).  
EMGdi%max was used as an index of inspiratory neural drive (IND) to the crural 
diaphragm. The ratio between EMGdi%max and tidal volume expressed relative to predicted vital 
capacity (EMGdi%max:VT%predVC) was used as an index of neuromechanical dissociation (NMD) of 
the respiratory system (9). Neuromuscular efficiency of the diaphragm was defined as the ratio of 
EMGdi%max:tidal Pdi%max (6).  
Results 
Compared with healthy controls, patients with COPD had greater COPD assessment test (CAT) 
score, poorer health-related quality of life (St. George’s Respiratory Questionnaire) and lower 
habitual physical activity (Community Healthy Activities Model Program for Seniors 
questionnaire), all p<0.001 (table E1). In average, patients had severe airflow obstruction [forced 
expiratory volume in one-second (FEV1): 40±18 %predicted] and 4/16 had moderate severity 
(80>FEV1≥50 %predicted). Table E1 also shows subjects’ comorbid conditions and medications. 
None of the subjects had significant cardiovascular or pulmonary vascular disease that could 
contribute to dyspnoea or orthopnoea.  
In supine (vs. sitting), controls’ inspiratory capacity (IC) increased by 0.48L (p<0.001) 
(figure E1) likely reflecting lower end-expiratory lung volume (EELV). In contrast to controls, 
patients’ IC and EELV were similar in both positions (figure E1).   
Patients had greater dyspnoea in all 5 domains in both positions compared with healthy 
controls (all p<0.05) and dyspnoea ratings increased significantly in the transition from seated to 
supine position in patients (p<0.05), figure E2.  
Fifteen of sixteen participants in each group accepted the insertion of the EMGdi-pressure 
catheter. EMGdi,max and Pdi,max were lower in supine versus sitting positions in both groups 
(p<0.05) (figure E3 and E4). While tidal EMGdi and Pdi were not significantly different between 
positions, values were greater in COPD patients compared with controls regardless of the position.  
EMGdi%max and tidal Pdi%max were greater in supine versus sitting position only in patients 
with COPD and values remained unaltered in healthy controls. Looking at individual EMGdi data 
(figure E3), 53% of patients showed a rise in tidal EMGdi in supine versus sitting position and the 
mean value tended to be higher while supine, though not significant. As such, higher EMGdi%max 
in supine versus sitting position in patients with COPD was a result of both higher numerator and 
lower denominator in variable combination. While in healthy controls, the majority (73%) showed 
a drop in their tidal EMGdi in supine versus sitting (figure E3). Similarly, higher tidal Pdi%max in 
supine versus sitting position in COPD patients was a result of higher tidal Pdi (i.e. numerator) 
and lower Pdi,max (i.e. denominator) in variable combination (figure E4).  
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Table E1: Subjects Characteristics 
 Variable COPD (n=16) CTRL (n=16) 
CAT score (0-40) 21.3±7.8* 4.3±3.5 
SGRQ total score 50.7±14.3* 3.4±1.8 
CHAMPS, kcal/wk for all activities 2102±1843* 5342±4240 
Comorbidities, no of subjects (%) 
 Hypertension 
 Diabetes Mellitus 


























 Combined LABA/LAMA 
 ICS 















Other medications, no. of subjects (%) 
 Anti-hypertensive  
 Statin 
 Anti-depressant 
 Thyroid replacement  
 Anti-angina medication 















Values are means±SD.  
* p<0.05 COPD vs. CTRL group. 
Abbreviations: CAT= COPD Assessment Test; CHAMPS= Community Healthy Activities Model 
Program for Seniors questionnaire; COPD= chronic obstructive pulmonary disease; CTRL= 
healthy controls; ICS= inhaled corticosteroid; LABA= long-acting beta2-agonist; LAMA= long-
acting muscarinic antagonist; SABA= short-acting beta2-agonist; SAMA= short-acting muscarinic 






Figure Legends  
Figure E1. Resting lung volumes in sitting and supine positions in patients with advanced COPD 
and age-matched healthy controls. Note the significant increase in inspiratory capacity (IC) in 
healthy controls while supine by 0.48 L (p<0.001) as a result of reduced EELV; assuming total 
lung capacity did not change with posture. The small sitting IC remained unaltered while supine in 
patients with COPD. Abbreviations: COPD= chronic obstructive pulmonary disease; EELV= end-
expiratory lung volume; IRV= inspiratory reserve volume; VT= tidal volume.  
Figure E2: Qualitative dyspnoea descriptors using the modified 10-point Borg scale in sitting and 
supine positions in patients with advanced COPD. Boxes depict the first to third quartiles; central 
lines denote the median. Whiskers range from the 10th to the 90th percentile. *p<0.05 sitting 
versus supine in patients with COPD.  
Figure E3. Individual diaphragm electromyography (EMGdi) data are shown in patients with 
advanced COPD and age-matched healthy controls (CTRL). Data are shown as absolute tidal 
inspiratory EMGdi (panels (a) and (b)) and as maximum values during serial sniff or inspiratory 
capacity manoeuvres (EMGdi,max) (panels (c) and (d)) in supine and sitting positions. Square 
symbols represent means. *p<0.05 sitting versus supine in patients or CTRL. Abbreviations: 
COPD= chronic obstructive pulmonary disease, CTRL= healthy controls. 
Figure E4. Individual trans-diaphragmatic pressure (Pdi) data are shown in patients with 
advanced COPD and age-matched healthy controls (CTRL). Data are shown as absolute tidal Pdi 
(panels (a) and (b)) and as maximum values during serial sniff manoeuvres (Pdi,max) (panels (c) 
and (d)) in supine and sitting positions. Square symbols represent means. *p<0.05 sitting versus 
supine in patients or CTRL. Abbreviations: COPD= chronic obstructive pulmonary disease, 
CTRL= healthy controls. 
 
 
 
 
